Kin Yip Leung
Director/Board Member at NOVOCURE LIMITED
Net worth: 967 870 $ as of 2024-04-29
Profile
Kin Yip Leung is currently the Vice Chairman at NovoCure Ltd.
He previously worked as an Independent Director at Curia Global, Inc. from 2010 to 2016, Director at Delcath Systems, Inc. in 2014, Director at NanoMed Pharmaceuticals, Inc., Independent Non-Executive Director at Pernix Therapeutics Holdings, Inc. from 2016 to 2019, Principal at Bristol Myers Squibb Co. from 1990 to 1999, EVP, President-Oncology & Diabetes Business at OSI Pharmaceuticals, Inc. from 2003 to 2010, and Group Vice President-Global Prescription Business at Pharmacia Corp.
from 1999 to 2003.
Mr. Leung is a member of C-Change.
He received his undergraduate degree from The University of Texas at Austin and his graduate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD.
0.07% | 2024-04-01 | 79,139 ( 0.07% ) | 967 870 $ | 2024-04-29 |
Kin Yip Leung active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Director/Board Member | 2011-08-04 |
Former positions of Kin Yip Leung
| Companies | Position | End |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Director/Board Member | 2019-05-08 |
| ALBANY MOLECULAR RESEARCH, INC. | Director/Board Member | 2016-02-03 |
| DELCATH SYSTEMS, INC. | Chairman | 2014-09-14 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2009-12-31 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | 2003-03-31 |
Training of Kin Yip Leung
| The University of Texas at Austin | Undergraduate Degree |
| University of Wisconsin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private companies | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services NanoMed Pharmaceuticals, Inc. developed therapeutic and diagnostic products. The company was founded by Michael Jay, Stephen Benoit and Russell J. Mumper in 2000 and was headquartered in Kalamazoo, MI. | Commercial Services |
| C-Change | |
Curia Global, Inc.
 Curia Global, Inc. Miscellaneous Commercial ServicesCommercial Services Curia Global, Inc. engages in drug research and development, and manufacturing. It offers drug delivery, drug development, analytical services, API development and manufacturing, and drug product solutions. The company was founded by Thomas E. D'Ambra on June 19, 1991 and is headquartered in Albany, NY. | Commercial Services |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
- Stock Market
- Insiders
- Kin Yip Leung
